Baxter International | BAX - Market Capitalization


Baxter International reported $14.12B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 158.05B 20.36B Jun/2026
AngioDynamics USD 511M 94M Sep/2025
Artivion USD 2.18B 176M Dec/2025
AtriCure USD 1.42B 28M Jun/2026
Baxter International USD 11.01B 2.34B Jun/2026
Becton, Dickinson and Co. USD 44.77B 10.52B Mar/2026
Boston Scientific USD 63.44B 29.82B Jun/2026
Cooper Companies USD 12.27B 3.68B Mar/2026
Dexcom USD 25.99B 1.82B Jun/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Globus Medical USD 11.69B 2M Mar/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Insulet USD 14.53B 5.46B Mar/2026
Integra LifeSciences USD 1.4B 664M Jun/2026
Intuitive Surgical USD 140.84B 22.89B Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Laboratory Of America USD 22.96B 1.03B Jun/2026
Merit Medical Systems USD 4.14B 25M Jun/2026
Quest Diagnostics USD 23.46B 1.77B Jun/2026
Smith & Nephew USD 3.54B 9.16B Aug/2026
Stryker USD 120.7B 5.15B Jun/2026
Teleflex USD 5.3B 99M Mar/2026
Terumo JPY 3.12T 228.98B Mar/2026
Zimmer Biomet Holdings USD 17.5B 321M Mar/2026